Xylyx Bio
1 follower
Xylyx Bio's platform technology of tissue-specific ECM substrates, clinically relevant data packages, and compound testing services increases predictiveness and informs better decision making in drug discovery, saving precious time and money in the quest to develop lifesaving drugs.
Org chart
Andrea Nye
CEO
Andrea Nye
Collapse
John O'Neill
Chief Scientific Officer
Alexandra Chiu
Director of Operations & Product Development
Sue Halligan
Co-Founder
